Whistleblower News From The Inside — July 15, 2016
By the C|C Whistleblower Lawyer Team Ex-drug executive Shkreli to face U.S. fraud trial in June 2017 -- Martin Shkreli, the former pharmaceutical executive who last year became a lightning rod for criticism of soaring prescription drug prices, is now scheduled to go on trial in June 2017 in the U.S. government's securities fraud case against him. Reuters Columbia University to pay $9.5 million to settle fraud charges -- The...